HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting.

AbstractINTRODUCTION:
The Matrix model of substance use treatment has been evaluated extensively in the United States as an effective treatment for methamphetamine use disorders. Since 2007, the Matrix model has been implemented in Cape Town, South Africa, where one in four treatment-seeking individuals are primarily opioid rather than stimulant users. Yet, there has been limited data on the application of the Matrix model for other types of substance use disorders in a resource-limited setting.
METHODS:
We compared primary opioid and primary methamphetamine users seeking treatment at the first certified Matrix model substance use treatment site in Cape Town, South Africa from 2009 to 2014 (n=1863) on engagement in treatment, an important early predictor of later substance use treatment outcomes, and urine-verified abstinence at treatment exit.
RESULTS:
Compared to primary opioid users, primary methamphetamine users had over 50% greater odds of initiating treatment (defined as attending at least one treatment session following intake; OR=1.55; 95%CI: 1.24-1.94), and 4.5 times greater odds of engaging in treatment (i.e., attending at least four treatment sessions; OR=4.48; 95%CI: 2.27-8.84). There were no significant differences in rates of urine-verified abstinence at treatment exit.
CONCLUSIONS:
Results suggest primary opioid users may experience additional barriers to treatment initiation and engagement in the Matrix model of substance use treatment, yet those who enter treatment are equally as likely to be abstinent at treatment exit compared to primary methamphetamine users. Findings highlight the need for additional strategies to optimize treatment initiation and engagement among primary opioid users in this setting, for instance by integrating medication-assisted treatment (e.g., methadone).
AuthorsJessica F Magidson, Hetta Gouse, Warren Burnhams, Christie Y Y Wu, Bronwyn Myers, John A Joska, Adam W Carrico
JournalAddictive behaviors (Addict Behav) Vol. 66 Pg. 132-137 (03 2017) ISSN: 1873-6327 [Electronic] England
PMID27940387 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2016 Elsevier Ltd. All rights reserved.
Chemical References
  • Central Nervous System Stimulants
  • Methamphetamine
Topics
  • Adult
  • Amphetamine-Related Disorders (epidemiology, rehabilitation)
  • Analysis of Variance
  • Central Nervous System Stimulants
  • Female
  • Humans
  • Male
  • Methamphetamine
  • Opiate Substitution Treatment (statistics & numerical data)
  • Opioid-Related Disorders (epidemiology, rehabilitation)
  • Patient Acceptance of Health Care (statistics & numerical data)
  • Retrospective Studies
  • Socioeconomic Factors
  • South Africa (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: